Mr. Nikhil Nath
Nikhil Nath is an Oncology Analyst at IQVIA in the Real World Solutions (RWS) Division. In this role, he works with pharmaceutical industry leaders on projects related to cancer and rare disease therapies. Nikhil advises clients and internal teams on topics, such as market access, reimbursement pathways, M&A, and oncology outcomes.
With a passion for ML and AI-driven decision-making, Nikhil is well-versed in predictive modelling, data integration strategies, and the usage of population-level data to improve patient care. Prior to his work in the private sector, he held an Analyst role at the Canadian Institute of Health Information (CIHI), where he worked with pan-Canadian health data related to Pharmaceuticals and Specialized Care.
He has held numerous research positions at Southlake Regional Health Centre (SRHC), St. Michael’s Hospital (SMH), Tufts University School of Medicine (TUSM) in Boston, MA, and the Western Cape Department of Health in Cape Town, South Africa, where he has published manuscripts on topics ranging from cardiovascular disease to COVID-19. Nikhil has a BSc in Life Sciences from Queen’s University and an MPH, with a concentration in Epidemiology and Biostatistics, from the Tufts University School of Medicine.